{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:38:52Z","timestamp":1787503132199,"version":"build-2736575974"},"reference-count":22,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Infective endocarditis (IE) remains a severe infection with high morbidity and mortality, particularly among people who inject drugs (PWID). Data from Eastern Europe are limited, despite the increasing burden of intravenous drug use in the region. Materials and Methods: We conducted a retrospective, observational cohort study of 153 patients diagnosed with IE and admitted to the \u201cDr. Victor Babe\u0219\u201d Clinical Hospital for Infectious and Tropical Diseases in Bucharest, Romania, between August 2019 and July 2024. Patients were classified into PWID (n = 51) and non-PWID (n = 102). Clinical characteristics, microbiological profiles, echocardiographic findings, complications, and outcomes (in-hospital, 10-week, and 12-month mortality) were compared between groups. Results: PWID were significantly younger (mean 34.0 \u00b1 6.6 years vs. 64.3 \u00b1 13.1 years; p &lt; 0.001), predominantly male (86.3% vs. 62.7%; p = 0.003) and had higher rates of HIV (64.7%) and HCV (98.1%). Right-sided IE and larger vegetations were more common in PWID, whereas non-PWID had more left-sided disease, pre-existing valvular pathology, and prosthetic valve involvement. Staphylococcus aureus predominated in PWID (68.6% vs. 27.5%; p &lt; 0.001), while non-PWID had more Streptococcus spp. and Coxiella burnetii cases. Embolic complications, particularly pulmonary emboli, and valvular rupture were significantly more frequent in PWID, while non-PWID had higher rates of heart failure and surgical interventions. In-hospital mortality was similar (17.6% vs. 11.8%; p = 0.318), but 12-month mortality was higher in PWID (27.5% vs. 13.7%; p = 0.038). Conclusions: IE in PWID shows a distinct clinical and microbiological profile, with more aggressive complications and worse long-term survival. Tailored management, early diagnosis, harm reduction programs, and dedicated follow-up are urgently needed in this high-risk population.<\/jats:p>","DOI":"10.3390\/medicina61101785","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T15:07:48Z","timestamp":1759417668000},"page":"1785","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characteristics of Infective Endocarditis in Intravenous Drug Users vs. Non-Users: A Retrospective Study Conducted in Bucharest, Romania"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9379-432X","authenticated-orcid":false,"given":"Adina-Alexandra","family":"Nanu","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"\u201cDr. Victor Babe\u0219\u201d Clinical Hospital of Infectious and Tropical Diseases, 030303 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos \u0218tefan","family":"Laz\u0103r","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"\u201cDr. Victor Babe\u0219\u201d Clinical Hospital of Infectious and Tropical Diseases, 030303 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6316-0333","authenticated-orcid":false,"given":"Corneliu Petru","family":"Popescu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"\u201cDr. Victor Babe\u0219\u201d Clinical Hospital of Infectious and Tropical Diseases, 030303 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miruna-Ioana","family":"Laz\u0103r","sequence":"additional","affiliation":[{"name":"\u201cNicolae Malaxa\u201d Clinical Hospital, 022441 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nica","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"\u201cDr. Victor Babe\u0219\u201d Clinical Hospital of Infectious and Tropical Diseases, 030303 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6482-3386","authenticated-orcid":false,"given":"Simin Aysel","family":"Florescu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"\u201cDr. Victor Babe\u0219\u201d Clinical Hospital of Infectious and Tropical Diseases, 030303 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/jth.14736","article-title":"Coagulation: At the heart of infective endocarditis","volume":"18","author":"Liesenborghs","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17293","DOI":"10.1161\/JAHA.120.017293","article-title":"Right-Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment","volume":"9","author":"Shmueli","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.athoracsur.2020.09.013","article-title":"Surgery for Endocarditis in Intravenous Drug Users","volume":"112","author":"Bearpark","year":"2021","journal-title":"Ann. Thorac. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.1016\/S2468-2667(19)30156-2","article-title":"Are we facing an opioid crisis in Europe?","volume":"4","author":"Verhamme","year":"2019","journal-title":"Lancet Public Health"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Loghin, I.I., Surdu, A.E., Rusu, \u0218.A., Cecan, I., Dorob\u0103\u021b, V.D., Mih\u0103escu, A.A., and Dorob\u0103\u0163, C.M. (2025). Etiological Aspects of Infectious Endocarditis in a Tertiary Hospital in Northeastern Romania. Medicina, 61.","DOI":"10.3390\/medicina61010095"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2022.03.349","article-title":"Diagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art Review","volume":"79","author":"Yucel","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.atssr.2023.02.025","article-title":"Revisiting Ethical Considerations in Recurrent Injection Drug Use-Related Infective Endocarditis","volume":"1","author":"Hull","year":"2023","journal-title":"Ann. Thorac. Surg. Short Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.idc.2020.06.004","article-title":"Infective endocarditis in persons who use drugs: Epidemiology, current management, and emerging treatments","volume":"34","author":"Schranz","year":"2020","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e2437861","DOI":"10.1001\/jamanetworkopen.2024.37861","article-title":"Infective Endocarditis Among Women Who Inject Drugs","volume":"7","author":"Adams","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Rigau, P.V., Moral, S., Bosch, D., Morales, M., Frigola, J.M., Albert, X., Robles, R., Ballesteros, E., Roqu\u00e9, M., and Aboal, J. (2020). Clinical Prognosis of Right-Sided Infective Endocarditis not Associated with Cardiac Devices or Intravenous Drug use: A Cohort Study and Meta-Analysis. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-64220-z"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejim.2013.01.010","article-title":"Native valve right sided infective endocarditis","volume":"24","author":"Akinosoglou","year":"2013","journal-title":"Eur. J. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1093\/eurheartj\/ehz620","article-title":"Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: A prospective cohort study","volume":"40","author":"Habib","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)","volume":"36","author":"Habib","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Thakarar, K., Rokas, K.E., Lucas, F.L., Powers, S., Andrews, E., DeMatteo, C., Mooney, D., Sorg, M.H., Valenti, A., and Cohen, M. (2019). Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225460"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"ofac150","DOI":"10.1093\/ofid\/ofac150","article-title":"Correlates of 90-Day Mortality Among People Who Do and Do Not Inject Drugs With Infective Endocarditis in Seattle, Washington","volume":"9","author":"Corcorran","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cid\/ciz869","article-title":"Long-term Outcomes Are Poor in Intravenous Drug Users Following Infective Endocarditis, Even After Surgery","volume":"71","author":"Straw","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"ofy304","DOI":"10.1093\/ofid\/ofy304","article-title":"Repeat Infective Endocarditis in Persons Who Inject Drugs: \u2018Take Another Little Piece of my Heart\u2019","volume":"5","author":"Huang","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"ofaf057","DOI":"10.1093\/ofid\/ofaf057","article-title":"Infective Endocarditis in People Who Inject Drugs\u2014A 5-Year Follow-up: \u201cI\u2019ve Seen the Needle and the Damage Done\u201d","volume":"12","author":"Halavaara","year":"2025","journal-title":"Open Forum Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jacc.2020.11.062","article-title":"Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs","volume":"77","author":"Llopis","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cecchi, E., Corcione, S., Lupia, T., De Benedetto, I., Shbaklo, N., Chirillo, F., Moreo, A., Rinaldi, M., Faggiano, P., and Cecconi, M. (2022). Infective Endocarditis in People Who Inject Drugs: Report from the Italian Registry of Infective Endocarditis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11144082"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e185220","DOI":"10.1001\/jamanetworkopen.2018.5220","article-title":"Clinical Characteristics and Factors Associated With Mortality in First-Episode Infective Endocarditis Among Persons Who Inject Drugs","volume":"1","author":"Rodger","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Goodman-Meza, D., Weiss, R.E., Gamboa, S., Gallegos, A., Bui, A.A.T., Goetz, M.B., Shoptaw, S., and Landovitz, R.J. (2019). Long term surgical outcomes for infective endocarditis in people who inject drugs: A systematic review and meta-analysis. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4558-2"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/10\/1785\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T15:44:42Z","timestamp":1759419882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/10\/1785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":22,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["medicina61101785"],"URL":"https:\/\/doi.org\/10.3390\/medicina61101785","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]}}}